To the content
4 . 2020

Type 2 diabetes mellitus and risk factors for cardiovascular disease. The advantage of choosing drugs iSGLT-2 and arGPP-1

Abstract

The aim of the study was to evaluate the effect of drugs SGLT-2 or arGPP-1 on the treatment of type 2 diabetes in patients with cardiovascular risks. As a result of the study, it was found that drugs of the SGLT-2 and arGPP-1 are especially attractive due to their positive influence on body weight, lipid profile, cardio- and nephroprotective effects.

Keywords: diabetes mellitus, risk factors

Funding. The study had no sponsor support.

Conflict of interests. The author declare no conflict of interests.

For citation: Adilyeva A.A. Type 2 diabetes mellitus and risk factors for cardiovascular disease. The advantage of choosing drugsiSGLT-2 and arGPP-1. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2020; 9 (4): 88–9. DOI: https://doi.org/10.33029/2304-9529-2020-9-4-88-89 (in Russian)

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Ametov Alexander S.
Honored Scientist of the Russian Federation, Doctor of Medical Sciences, Professor, Head of Subdepartment of Endocrinology, Head of the UNESCO Network Chair on the subject «Bioethics of diabetes as a global problem» of the Russian Medical Academy of Continuous Professional Education (Moscow)
Вскрытие

Journals of «GEOTAR-Media»